Moderna (MRNA) EBIT Margin (2017 - 2025)
Historic EBIT Margin for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to 25.59%.
- Moderna's EBIT Margin fell 218300.0% to 25.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 155.15%, marking a year-over-year decrease of 1014600.0%. This contributed to the annual value of 121.91% for FY2024, which is 600100.0% down from last year.
- Moderna's EBIT Margin amounted to 25.59% in Q3 2025, which was down 218300.0% from 638.73% recorded in Q2 2025.
- In the past 5 years, Moderna's EBIT Margin registered a high of 75.02% during Q4 2021, and its lowest value of 972.22% during Q1 2025.
- Moreover, its 5-year median value for EBIT Margin was 3.76% (2024), whereas its average is 184.45%.
- Per our database at Business Quant, Moderna's EBIT Margin skyrocketed by 17028600bps in 2021 and then crashed by -7384300bps in 2024.
- Quarter analysis of 5 years shows Moderna's EBIT Margin stood at 75.02% in 2021, then crashed by -59bps to 31.08% in 2022, then plummeted by -99bps to 0.21% in 2023, then tumbled by -60530bps to 128.99% in 2024, then soared by 80bps to 25.59% in 2025.
- Its EBIT Margin was 25.59% in Q3 2025, compared to 638.73% in Q2 2025 and 972.22% in Q1 2025.